Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS005 in Healthy Volunteers
NCT04220073Phase 1Completed
- Sponsor
- Shanghai Junshi Biosciences Co., Ltd.
- Start
- May 2020
- Primary completion
- Nov 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in psoriasis comparing JS005 with Placebo (2 arms). Primary endpoint: Number of Participants With Clinically Significant Events at 12 weeks. Started May 2020; status: completed.
02
Drugs
roconkibart
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT04220073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04220073.